ANP 1-28, HUMAN

ANP 1-28, HUMAN

89213-87-6

C₁₂₇H₂₀₃N₄₅O₃₉S₃

O=C(N[C@@H](CCCNC(N)=N)C(N[C@](C(O)=O)CC1=CC=C(O)C=C1)=O)[C@@H](NC([C@](CO)NC([C@](CC(N)=O)NC([C@@H](NC(CNC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@](N2)([H])[C@@H](C)CC)=O)=O)C)=O)CCC(N)=O

[99-126]-human proatriopeptin ; a-human atrial natriuretic hormone ; a-human atrial natriureticpolypeptide ; ahanf, carperitide ; human a-atriopeptin ; sun 4936 ; anp 1-28, human ; human a-atrial natriuretic factor ; α-hanp ; human atriopeptin(1-28) ; 1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontane,cyclic peptide deriv. ; horse atrial natriuretic peptide-28 ; 82: pn: us20080153747 seqid: 82 claimed protein ; 2: pn: us6028055 seqid: 51 claimedprotein ; human a-atrial natriuretic peptide ; anf 1-28, human ; human atrial natriuretic peptide (99-126) ; l-tyrosine,l-seryl-l-leucyl-l-arginyl-l-arginyl-l-seryl-l-seryl-l-cysteinyl-l-phenylalanylglycylglycyl-l-arginyl-l-methionyl-l-a-aspartyl-l-arginyl-l-isoleucylglycyl-l-alanyl-l-glutaminyl-l-serylglycyl-l-leucylglycyl-l-cysteinyl-l-asparaginyl-l-seryl-l-phenylalanyl-l-arginyl-,cyclic (7? ; atrial natriureticpeptide-28 (human) (9ci) ; α-atriopeptin【human】 ; human a-atrial natriuretic factor(1-28) ; humanatriopeptin(99-126) ; a-atriopeptin (human) ; 4: pn: us20090011997 seqid: 2 claimed protein ; anp, alpha-, human ; a-human atrial natriuretic peptide (1-28) ; hanf ; 13: pn:us20060171920 seqid: 13 claimed protein ; human atrial natriuretic peptide (1-28) ; human atriopeptin-28 ; anp human, 1-28 ; atriopeptin-33(rat), 1-de-l-leucine-2-de-l-alanine-3-deglycine-4-de-l-proline-5-de-l-arginine-17-l-methionine- ; carperitide ; 56: pn: us20090011997seqid: 59 claimed protein ; (1-28)-human atrial natriuretic peptide ; humanatrial natriuretic factor (99-126) ; carperitide acetate ; a-humanatriopeptin(1-28) ; atriopeptin (human a-component)